Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.

D. Assimos

DOI: https://doi.org/10.1016/j.juro.2016.12.033

2017-03-01

Abstract:

What problem does this paper attempt to address?

Finite-time consensus of heterogeneous multi-agent system with external disturbances

Jue Ling,Ronghao Wang

DOI: https://doi.org/10.1109/CAC.2017.8243000

2017-10-01

Abstract:Finite-time consensus of heterogeneous multi-agent system (MAS) with external disturbances is investigated in this paper. Distributed control algorithm is designed for the agents described by leaderless MAS. It can be shown that the state errors of any two agents reach a region in finite time with external disturbances by using Lyapunov stability analysis and algebraic graph theory. At last, one example is provided to illustrate the effectiveness of the theoretical analysis.
Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet

Mahmoud Teaima,Sandra Hababeh,Mai Khanfar,Fares Alanazi,Doaa Alshora,Mohammed El-Nabarawi

DOI: https://doi.org/10.3390/pharmaceutics14020425

IF: 6.525

2022-02-16

Pharmaceutics

Abstract:Pioglitazone Hydrochloride (PGZ) suffers from poor aqueous solubility. The aim of this research was to design orally disintegrating tablets with self-nanoemulsifying properties (T-SNEDDS) to improve the Pioglitazone solubility and dissolution rate. Three liquid self-nanoemulsifying systems (L-SNEDDS) were formulated and evaluated for transmittance percentage, emulsification time, particle size, Poly dispersity index (PDI), percentage of content, solubility and stability. The optimum L-SNEDDS formula was converted to a solidified self-nanoemulsifying drug delivery system (S-SNEDDS) by adsorption on Syloid (SYL). Powder characterization tests, such as flowability tests, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and scanning electron microscopy (SEM), were performed for the selected S-SNEDDS formulation. Orally disintegrating tablets (ODT) were formulated by blending S-SNEDDS with tableting excipients. The ODT tablet batch composed of Prosolv was selected for tablet quality control tests, such as hardness, friability, disintegration time, content uniformity, weight variation, in vitro release, in vivo studies and accelerated stability studies. ODT tablets showed accepted mechanical properties and rapid disintegration time ( 0.05). In vivo pharmacokinetic and pharmacodynamic evaluation of ODTs showed better behavior compared to the raw drug suspension and the commercial tablet (p > 0.05). Orally disintegrating tablets revealed a promising potential to improve Pioglitazone poor aqueous solubility, dissolution profile and bioavailability.

pharmacology & pharmacy
Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance

Mohammed Asadullah Jahangir,Ruqaiyah Khan,Syed Sarim Imam

DOI: https://doi.org/10.1080/21691401.2017.1411933

2017-12-09

Abstract:PURPOSE: The aim of the study to formulate and statistically optimize sitagliptin-loaded eudragit nanoparticles (SIT-NPs) and evaluate the in-vitro pharmaceutical quality and in-vivo anti-diabetic assessment.METHOD: SIT-NPs were prepared by using combination method of solvent evaporation and nano-precipitation techniques. The influence of different independent variables as eudragit RL100 concentration (%), tween 80 concentration (%) and sonication time (min) were evaluated on dependent variables like particle size (nm), drug loading (%) and in-vitro drug release (%). Further, the optimized formulation was evaluated for surface morphology, CLSM, ex-vivo permeation study and in-vivo anti-diabetic activity and stability study.RESULTS: The developed SIT-NPs formulations showed particle size range (135.86-193.45 nm), drug loading (6.36-8.76%) and prolonged drug release over 24 h. The prepared SIT-NPs were found to be nearly spherical with smooth surface. The comparative in-vitro release study and CLSM study results revealed that SIT-NPopt showed significantly (p < .05) enhanced release and permeation as compared to SIT free solution (SIT-Fs). The in-vivo anti-diabetic assessment revealed that SIT-NPopt able to reduce the blood sugar level (BSL) for a prolonged period of time. Further, the stability study data showed the formulations were found stable at both temperature and having the shelf life of 488 d.CONCLUSIONS: This research has shown that SIT-NPs based on experimental design offers a new and better approach to delivering SIT, thus encouraging further development of this formulation.

biotechnology & applied microbiology,engineering, biomedical,materials science, biomaterials
FORMULATION DEVELOPMENT AND OPTIMIZATION OF EMPAGLIFLOZIN FILM COATED TABLET USING QUALITY-BY-DESIGN APPROACH

ATUL PHATAK,MAHESH BHADAGALE,VARDHAMAN BAFNA,SHRADDHA LAKAMBARE

DOI: https://doi.org/10.22159/ajpcr.2023.v16i1.46037

2023-01-07

Asian Journal of Pharmaceutical and Clinical Research

Abstract:Objective: Development of robust and effective oral solid immediate release film coated tablet of empagliflozin using Quality-by-Design (QbD) approach was the objective of present research work. This belongs to Sodium Glucose Co-Transporter-2 inhibitors-oral hypoglycemic class to treat Type-2 diabetes mellitus and associated cardiovascular comorbidities. Methods: Assessment of risk factors (using Ishikawa fishbone diagram) was done by in-depth understanding of quality target product profile and critical quality attributes (CQAs) associated with material and process with justification. Randomized regular two levels full factorial design in addition with 5-center points was employed as Design of Experiment (DoE) tool. In this design, independent factors were concentrations of hydroxyl propyl cellulose (HPC SL) and croscarmellose sodium in mg. The responses selected for study were % drug release at 15-min in vitro dissolution time, disintegration time in sec, and hardness in Newton. Results: ANOVA and lack-of-fit demonstrated that stipulated independent variables have significant impact on response variables and best correlation was seen in actual and predicted value. This optimization method confirmed that HPC SL (8 mg) and croscarmellose sodium (4 mg) were ideal concentrations of binder and disintegrant, respectively, to prepare said formulation with desired quality attributes and it was found to be better with respect to stability and effectiveness against marketed reference formulation. Conclusion: QbD tools such as QTPP, CQAs, risk assessment, and DoE can be used in combination to optimize, screen, and understand the function of material and process parameters on quality characteristics of film-coated tablet.
Peristaltic squeezing of sperm bundles at the late stage of spermatogenesis in the silkworm, Bombyx mori

N. Kawamura,N. Yamashiki,Hiroshi Saitoh,K. Sahara

DOI: https://doi.org/10.1002/1097-4687(200011)246:2<53::AID-JMOR1>3.0.CO;2-P

2000-11-01

Journal of Morphology

Abstract:Silkworm (Lepidoptera) males produce dimorphic sperm, nucleate eupyrene sperm, and anucleate apyrene sperm. The eupyrene sperm is the ordinary sperm fertilizing eggs, while the function of the apyrene sperm, which are about four times as numerous as the eupyrene sperm, is still uncertain. We found the peristaltic phenomenon at the very late stage of spermatogenesis. Peristalsis occurs in both eupyrene and apyrene sperm bundles. Through peristaltic action, cytoplasm of the eupyrene sperm and both cytoplasm and nuclei of the apyrene sperm are discarded from the posterior end of the sperm bundles. Peristaltic squeezing seems to be a process to eliminate the irregular nuclei of apyrene sperm while preserving the nuclei of eupyrene sperm. J. Morphol. 246:53–58, 2000. © 2000 Wiley‐Liss, Inc.
[Arrhythmologic study of 50 patients with arrhythmogenic disease of the right ventricle: prognostic implications].

R. Bettini,F. Furlanello,G. Vergara,G. Durante,A. Bertoldi,L. Visonǎ,P. Dal Forno,G. Camin,C. Burelli,G. Nicolosi

1989-07-01

Abstract:UNLABELLED Arrhythmogenic right ventricular disease is a syndrome which involves a wide spectrum of anatomo-clinical features. It is characterised by different levels of right ventricle anomaly, and by life-threatening "right" hyperkinetic ventricular arrhythmias. Fifty consecutive pts were retrospectively examined at the Arrhythmological Centre in Trento between 1977 and 1988. The results of rigorous arrhythmological, echocardiographic and angiographic criteria showed that all pts were affected by arrhythmogenic right ventricular disease. CASE STUDY 39/50 (78%) males, 11/50 (22%) females; age 30.6 years (11-78) at the time of the first study. METHODS clinical history in 50/50 pts, electrocardiogram in 50/50 pts, Holter monitoring in 50/50 pts, ergometric test in 49/50 pts, non-invasive analysis using signal-averaging QRS in 17/50 pts, 2D echocardiogram in 50/50 pts, angiography in 38/50 pts, electrophysiological endocavitary study in 35/50 pts. RESULTS familial 2/50 (4%); 1/50 (2%) was in class II NYHA; first arrhythmia at 24.6 years (8-60); most severe arrhythmia at 27.7 years (9-74). Forty-three out of fifty patients (86%) were symptomatic for arrhythmias: 28/50 (56%) as a result of stress; 20/50 (40%) had life-threatening symptoms; 6/50 (12%) had aborted sudden death. Arrhythmogenic right ventricular disease was "localized" in 42/50 (84%) and "diffused" in 8/50 (16%) and was associated with anomalies of the left ventricle in 30/50 (60%). Electrocardiogram showed: right bundle branch block in 10/50 (20%), negative T wave on the right precordial leads in 19/50 (38%), delayed ventricular potentials in 4/17 (23.5%). Using the electrocardiogram, Holter monitoring and electrophysiological endocavitary study the following were documented: a) clinical ventricular tachycardia in 40/50 (80%): non-sustained ventricular tachycardia in 10/50 (20%), sustained ventricular tachycardia in 30/50 (60%); b) electrically induced ventricular tachycardia in 26/35 (74.2%): non-sustained ventricular tachycardia in 8/35 (22.8%), sustained ventricular tachycardia in 18/35 (51.4%) (clinical sustained ventricular tachycardia in 18/18); c) multiform ventricular tachycardia in 12/50 (24%) (diffused arrhythmogenic right ventricular disease in 3/12 and associated anomalies of the left ventricle in 11/12); d) pleomorphic sustained ventricular tachycardia in 9/30 (30%) (diffused arrhythmogenic right ventricular disease in 2/9, and associated anomalies of the left ventricle in 8/9). Forty-two out of fifty patients (84%) underwent antiarrhythmic treatment. When the study was carried out 6.6 years (1 month-22 years) had passed since the first symptom; follow-up was 2.1 years (1 month-11 years) while the interval between the first symptom and the last check-up was 8.4 years (1-30 years); 2/50 dropped out and 2/50 died suddenly.(ABSTRACT TRUNCATED AT 400 WORDS)
Design, preparation, and in vitro evaluation of gastroretentive floating matrix tablet of mitiglinide

Meenakshi Patel,Santosh Shelke,Naazneen Surti,Prabhakar Panzade,Lamya Ahmed Al-Keridis,Tarun Kumar Upadhyay,Nawaf Alshammari,Mohd Saeed

DOI: https://doi.org/10.3389/fphar.2023.1140351

2023-03-15

Abstract:The present research is focused on developing floating matrix tablets of mitiglinide to prolong its gastric residence time for better absorption. Gastroretentive tablets were prepared using a direct compression technique with hydroxypropyl methylcellulose K15M (HPMC K15M) and sodium alginate as matrix-forming polymers and sodium bicarbonate as the gas-forming agent. A 32 full factorial design was adopted to optimize the flotation and release profile of the drug. The concentration of HPMC K15M and sodium alginate were taken as the independent variables, and the floating lag time, time required for 50% drug release, and time required for 90% drug release were taken as dependent variables. The compatibility between drug and excipients was assessed by Fourier transform infrared (FTIR) spectroscopy. The prepared tablets were evaluated for different parameters such as hardness, friability, drug content, floating time, in vitro dissolution, and stability. Dissolution data were analyzed using various kinetic models to ascertain the mechanism of drug release. Finally, a radiographic study was conducted to estimate the retention time of the optimized floating matrix tablets of mitiglinide inside the body. The results revealed that all the physical properties of the developed formulations were within standard limits. The formulation M3, with the maximum amount of both independent variables, was considered to be the optimized formulation based on the desirability value. In addition, the optimized M3 formulation showed stability for over 6 months, as evidenced by insignificant changes in lag time, drug release pattern, and other physical properties. Furthermore, radiographic examination indicated that the tablets remained afloat in gastric fluid for up to 12 h in the rabbit's stomach. In conclusion, the developed floating matrix tablet of mitiglinide could be regarded as a promising formulation that could release the drug in the stomach at a controlled rate and, hence, offer better management of type II diabetes.
Development of 3D-Printed, Liquisolid and Directly Compressed Glimepiride Tablets, Loaded with Black Seed Oil Self-Nanoemulsifying Drug Delivery System: In Vitro and In Vivo Characterization

Tarek A. Ahmed,Hanadi A. Alotaibi,Waleed S. Alharbi,Martin K. Safo,Khalid M. El-Say

DOI: https://doi.org/10.3390/ph15010068

IF: 4.6

2022-01-05

Pharmaceuticals

Abstract:Glimepiride is characterized by an inconsistent dissolution and absorption profile due to its limited aqueous solubility. The aim of this study was to develop glimepiride tablets using three different manufacturing techniques, as well as to study their quality attributes and pharmacokinetics behavior. Black seed oil based self-nanoemulsifying drug delivery system (SNEDDS) formulation was developed and characterized. Glimepiride liquisolid and directly compressed tablets were prepared and their pre-compression and post-compression characteristics were evaluated. Semi-solid pastes loaded with SNEDDS were prepared and used to develop three-dimensional printing tablets utilizing the extrusion technique. In vivo comparative pharmacokinetics study was conducted on Male Wistar rats using a single dose one-period parallel design. The developed SNEDDS formulation showed a particle size of 45.607 ± 4.404 nm, and a glimepiride solubility of 25.002 ± 0.273 mg/mL. All the studied tablet formulations showed acceptable pre-compression and post-compression characteristics and a difference in their in vitro drug release behavior. The surface of the liquisolid and directly compressed tablets was smooth and non-porous, while the three-dimensional printing tablets showed a few porous surfaces. The inner structure of the liquisolid tablets showed some cracks and voids between the incorporated tablet ingredients while that of the three-dimensional printing tablets displayed some tortuosity and a gel porous-like structure. Most of the computed pharmacokinetic parameters improved with the liquisolid and three-dimensional printed tablets. The relative bioavailabilities of the three-dimensional printed and liquisolid tablets compared to commercial product were 121.68% and 113.86%, respectively. Therefore, the liquisolid and three-dimensional printed tablets are promising techniques for modifying glimepiride release and improving in vivo performance but more clinical investigations are required.

pharmacology & pharmacy,chemistry, medicinal
Formulation, Optimization and Evaluation of Solid SMEDDS of Pioglitazone

Manisha R Patil,Sanjay K Kshirsagar

DOI: https://doi.org/10.25258/ijddt.14.1.21

2024-03-25

International Journal of Drug Delivery Technology

Abstract:This investigation assessed 32 formulations of liquid self-microemulsifying drug delivery system (L-SMEDDS) for pioglitazone (PGZ). The optimal PLS12 formulation comprises 40% capmul MC8 (oil), 40% cremophore RH40 (surfactant), and 20% PEG (co-surfactant). PLS12 exhibited approximately 75 nm droplet size, below 200 nm, and a PDI of 0.47, indicating nanosized droplets with uniform distribution. The formulation demonstrated stability, and achieved supreme drug loading capacity. The enhanced L-SMEDDS was solidified into solidified SMEDDS utilizing Sylloid 244 FP, subsequently in a free-flowing powder without drug interactions. Tablets were successfully formulated by incorporating S-SMEDDS with diverse tableting excipients. The selected tablet batch passed quality control and stability tests. The tablet exhibited a rapid and pH-independent release profile. The combined impact of SMEDDS and tablets collectively enhanced the solubility and dissolution of PGZ hydrochloride
FORMULATION DEVELOPMENT AND OPTIMISATION OF FAST DISSOLVING BUCCAL FILMS LOADED GLIMEPIRIDE SOLID DISPERSION WITH ENHANCED DISSOLUTION PROFILE USING CENTRAL COMPOSITE DESIGN

PARVEEN FAROOQUI,RAJASHREE GUDE

DOI: https://doi.org/10.22159/ijpps.2023v15i6.47992

2023-06-01

International Journal of Pharmacy and Pharmaceutical Sciences

Abstract:Objective: This study aimed to enhance the solubility and dissolution of Glimepiride, a new-generation hypoglycaemic agent with low water solubility, by preparing Fast dissolving buccal films (FDBFs) containing Glimepiride solid dispersion. Methods: Glimepiride solid dispersions were fabricated using Polyethylene Glycol 4000 as the carrier by Physical mixture, Solvent evaporation, Kneading, and Fusion method. The optimised solid dispersion was selected based on the drug content and in vitro dissolution data. The final films incorporated with solid dispersion were prepared by the solvent casting technique, wherein the film formulation was optimised using the design of experiment (DoE) approach by applying the Central Composite statistical design. The optimised film formulation was then evaluated for various parameters, including weight variation, folding endurance, disintegration time, thickness, surface pH, and dissolution studies. Results: Among the different methods employed, the kneading method using PEG 4000 in a drug-to-polymer ratio of 1:3 exhibited the highest drug content and in vitro drug release, making it the most promising option. The film formulation that was optimised displayed an accelerated in vitro drug dissolution within a time frame of 10 min, with an average disintegration time of 31.33±0.471. Conclusion: The developed FDBFs loaded with Glimepiride solid dispersion demonstrated a markedly improved dissolution profile, avoidance of extensive first-pass metabolism, and improved patient compliance. The results suggest that the developed FDBFs could be a potential alternative to conventional dosage forms of Glimepiride.
Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy

Ting-Ting Yan,Zhu-Fen Lv,Pan Tian,Min-Mei Lin,Wei Lin,Si-Yu Huang,Yan-Zhong Chen

DOI: https://doi.org/10.1080/03639045.2020.1734018

IF: 3.727

2020-03-12

Drug Development and Industrial Pharmacy

Abstract:Orodispersible films (ODFs) are promising drug delivery systems for customized medicines as it provide an alternative approach to increase consumer acceptance by advantages of rapid dissolution and administration without water. The aim of this study was to develop a platform to support the realization of tailored treatments suitable for the extemporaneous production of ODFs by semi-solid extrusion (SSE) 3D printing (3DP). Hydroxypropyl methyl cellulose (HPMC) was used as the polymer of ODFs, and levocetirizine hydrochloride was used as the model drug. The optimal formulation was HPMC:API:PS:maltitol:sucralose at a ratio of 64:10:10:15:1. Seventeen percent HPMC solution and optimal formulation were used to prepare film precursors. The impact of dynamic viscosities and fluid mechanics difference on printing applicability was discussed. The ODFs of cube designs with aimed dose of 1.25 mg, 2.5 mg, and 5 mg were printed by SSE 3DP. Good linear relationship between theoretical model volume and drug content (<i>R</i><sup>2</sup> = 0.999) and good dose accuracy indicate that 3DP is a suitable method for preparing individualized ODFs.

pharmacology & pharmacy,chemistry, medicinal
Formulation, design and optimization of antidiabetic drug loaded microspheres

Tabasum Siraj Mulla,Vijay Rajaram Salunkhe,Somnath Devidas Bhinge,Nitin Mohire

DOI: https://doi.org/10.1007/s00289-022-04325-9

IF: 2.843

2023-05-11

Polymer Bulletin

Abstract:The present research aim is to develop the tablet formulation containing microspheres and encapsulating microsphere with antidiabetic drug specially Sitagliptin Phosphate Monohydrate and poly lactic co glycolic acid (PLGA) as a polymer. Preformulation study of the selected drug was carried out. Then, the microspheres were prepared by factorial design, i.e., Design-Expert 12 software (Stat-Ease Inc., USA) was used for designing of experiment, to study interaction between independent variables and dependent variables and deriving optimum formulation. Spray dryer was used for preparation of microspheres. The zeta potential, particle size, infrared spectral analysis, scanning electron microscopy, % drug content, encapsulation efficiency and % drug release were evaluated. Optimized batch F3 showed an average particle size 2500.6 nm. The in vitro drug release at 12th hour and % drug entrapment efficiency of optimized batch F3 was found to be 92.35% and the 34.00%, respectively. The final product has lowered particle size 2500.6 nm and it is focused for well acceptable and suitable due to significant drug release. The final tablet was prepared from optimized batch F3. The precompression parameters, i.e., flow properties of granules, were carried out, and then, post-compression parameters like weight variation, thickness, hardness, friability, % drug content and % drug release were evaluated. The stability study and in vitro antidiabetic study was carried out for tablet. The final product is well acceptable, suitable, palatable, easy for administration and elegant.

polymer science
Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats

Tarek M. Ibrahim,Margrit M. Ayoub,Hany M. El-Bassossy,Hanan M. El-Nahas,Eman Gomaa

DOI: https://doi.org/10.3390/pharmaceutics14091867

IF: 6.525

2022-09-06

Pharmaceutics

Abstract:The aim of the study was to design injectable long-acting poly (lactide-co-glycolide) (PLGA)-based in situ gel implants (ISGI) loaded with the anti-diabetic alogliptin. Providing sustained therapeutic exposures and improving the pharmacological responses of alogliptin were targeted for achieving reduced dosing frequency and enhanced treatment outputs. In the preliminary study, physicochemical characteristics of different solvents utilized in ISGI preparation were studied to select a proper solvent possessing satisfactory solubilization capacity, viscosity, water miscibility, and affinity to PLGA. Further, an optimization technique using a 23 factorial design was followed. The blood glucose levels of diabetic rats after a single injection with the optimized formulation were compared with those who received daily oral alogliptin. N-methyl-2-pyrrolidone (NMP) and dimethyl sulfoxide (DMSO), as highly water-miscible and low viscous solvents, demonstrated their effectiveness in successful ISGI preparation and controlling the burst alogliptin release. The impact of increasing lactide concentration and PLGA amount on reducing the burst and cumulative alogliptin release was represented. The optimized formulation comprising 312.5 mg of PLGA (65:35) and DMSO manifested a remarkable decrease in the rats' blood glucose levels throughout the study period in comparison to that of oral alogliptin solution. Meanwhile, long-acting alogliptin-loaded ISGI systems demonstrated their feasibility for treating type 2 diabetes with frequent dosage reduction and patient compliance enhancement.

pharmacology & pharmacy
Preparation and Characterization of Febuxostat Nanosuspension as Fast Dissolving Oral Film

Zahraa Salim Alwan,Nawal Ayash Rajab

DOI: https://doi.org/10.54133/ajms.v6i2.873

2024-06-16

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )

Abstract:Background: Quickly dissolved oral films are a widely accepted method of delivering drugs and help patients adhere to treatment regimens. Nanosuspensions (NS) are colloidal dispersions of drug particles with a submicron size, and their large surface area enhances the solubility and dissolution of low-water-soluble drugs. Febuxostat (FXT) is a non-purine xanthine oxidase inhibitor with a low dissolution rate that limits its absorption. Objective: To develop fast-dissolving oral films (FDOFs) containing FXT NS and convert NS into solid dosage forms to ease administration and accelerate drug release. Methods: FXT NS was prepared using Soluplus as a stabilizer and Tween80 as a co-stabilizer through an anti-solvent precipitation technique. We prepared FDOFs using a solvent casting method, utilizing hydrophilic polymers like pullulan, polyvinyl alcohol (PVA), gelatin, and plasticizers like polyethylene glycol (PEG400) and glycerin. The study assessed the film's thickness, weight, folding endurance, drug content, disintegration time, and drug release. We validated the drug's compatibility using FTIR, and conducted a crystallinity study using DSC and X-ray powder diffraction. Results: F4 was the optimized formula prepared using PVA and PEG400. In just three minutes, the F4 dissolution rate increased significantly (99.63% vs. 11.23%) compared to the FXT ordinary film. Also, it had good mechanical properties. Conclusions: FXT NS were successfully loaded into FDOFs with accepted properties.
Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine

Laura Modica de Mohac,Maria de Fátima Pina,Bahijja Tolulope Raimi-Abraham

DOI: https://doi.org/10.1016/j.ijpharm.2016.05.012

2016-07-11

Abstract:In this study, we evaluate the dissolution rate enhancement of solid microcrystalline dispersion (SMD) films of olanzapine (OLZ) formulated with four water-soluble polymers namely poly(N-vinylpyrrolidone) (PVP), poloxamer 188 (P188), poloxamer 407 (P407) and Soluplus(®) (SLP). Prepared formulations were characterised to determine particle size, morphology, hydrogen bonding interactions, thermal characteristics as well as in vitro dissolution studies conducted under sink conditions (pH 6.8). Particle size of OLZ in all formulations ranged between 42 and 58μm. Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR), Differential Scanning Calorimetry (DSC) and Hot-Stage Microscopy (HSM) studies confirmed OLZ was well maintained in its crystalline state during the formulation process. In vitro dissolution studies showed immediate drug release from all formulation when compared to the drug alone. The greatest increase in in vitro dissolution rate was observed in formulations containing P188 most likely due to its enhanced hydrophilic and surfactant properties compared to the other agents used. Overall, this study successfully generated OLZ loaded SMD films with improved in vitro dissolution rates which is highly likely to result in improved oral bioavailability in vivo.
STATISTICAL DESIGN OF EXPERIMENT-BASED FORMULATION DEVELOPMENT AND OPTIMIZATION OF FLOATING MATRIX TABLET OF ANTI-EMETIC DRUG

GREATO DIAS,SUWARNA SURESH BOBDE,PRASAD DESAI

DOI: https://doi.org/10.22159/ijap.2024v16i4.50771

2024-07-07

International Journal of Applied Pharmaceutics

Abstract:Objective: To employ Design of Experiment (DOE) for designing a floating matrix tablet of Domperidone Maleate (DM) using novel direct compression grade polymer METHOCEL K4M DC2 that offers advantages of extended or sustained release, providing for cost-effective manufacturing. Methods: To prepare floating matrix tablets containing DM, the direct compression method was employed. The tablets were optimised using a 22 Central Composite Design (CCD). Concentration of the sustained release polymer METHOCEL DC2 K4M grade (X1= A) and Concentration of the floating agent potassium bicarbonate (KHCO3) (X2= B) were the independent variables selected whereas floating lag time (Y1), drug release at 1 h (Y2), 4 h (Y3), 6 h (Y4) and 8 h (Y5) were the 5 dependent variables employed in the study design. Fourier Transform Infrared (FTIR) analysis was utilised to analyse drug-excipient compatibility, revealing no discernible interaction, and various mathematical models were employed to study the drug release mechanism. Results: The prepared tablets were evaluated for weight, thickness, hardness, friability, and assay and the results were found to be satisfactory. The optimised formulation predicted by the software was found to have a desirability value of 0.982, containing 60 mg of METHOCEL DC2 K4M and 20 mg of KHCO3, was prepared and evaluated. Predicted and experimental results were found to be comparable for all the responses. All formulations were shown to fit well into Zero-order release kinetics, but the optimised formulation (F4), with R2= 0.9893 and n= 2.2797, exhibited the best fitting in both the Zero-order and Korsmeyers-Peppas model. Conclusion: The study conducted revealed that floating tablets of DM could be developed using KHCO3 as a gas-generating agent with sustained drug release till 14 h using polymer METHOCEL DC2 K4M.
Synthesis and characterization of novel xanthan gum-based pH-sensitive hydrogel for metformin hydrochloride release

Tushar,Yash Saraswat,Priyanka Meena,Sudhir G. Warkar

DOI: https://doi.org/10.1007/s00396-023-05135-9

2023-06-20

Abstract:In the current study, the synthesis of hydrogel based on carboxymethyl tamarind kernel gum (CMTKG), poly(sodium acrylate) (PSA), xanthan gum (XG) and its loading with metformin hydrochloride (metformin HCl) was successfully carried out and characterized using various techniques. Furthermore, the optimization of hydrogel was done by varying the amount of carboxyl methyl tamarind kernel gum (CMTKG), N , N ′-methylene-bis-acrylamide (MBA) or potassium persulphate (KPS), and their influence on the swelling ratio was examined. The fabricated hydrogels were characterized by attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM), whereas thermal stability was confirmed by thermogravimetry analysis (TGA). The hydrogels' swelling ratio and in vitro drug release studies were assessed in pH 1.2 and 7.4 buffer solutions and showed better results in alkaline pH. The drug release profile of metformin-loaded CMTKG/PSA/XG hydrogel obeyed the Korsmeyer–Peppas model and follow non-Fickian diffusion in pH 7.4 and Fickian diffusion mechanism at pH 1.2. This pH-dependent behaviour of the metformin HCl-loaded CMTKG/PSA/XG hydrogel could be applicable for site-specific release of metformin HCl.

polymer science,chemistry, physical
Formulation, Statistical Optimization, and In Vivo Pharmacodynamics of Cydonia oblonga Mucilage/Alginate Mucoadhesive Microspheres for the Delivery of Metformin HCl

Sobia Noreen,Sara Hasan,Shazia Akram Ghumman,Shoaib Anwar,Humaira Yasmeen Gondal,Fozia Batool,Shazia Noureen

DOI: https://doi.org/10.1021/acsomega.2c07789

IF: 4.1

2023-02-05

ACS Omega

Abstract:In recent years, attention has shifted toward the utilization of natural polymers for encapsulation and sustained release of health-hazardous drugs. The purpose of this work is to define and assess the sustained delivery potential and mucoadhesive potential of a Cydonia oblonga mucilage (COM) and sodium alginate (Na-Alg)-constituting polymeric delivery carrier of antidiabetic drugs with a specific end goal to retain metformin HCl in the stomach while expanding the drug's bioavailability. Metformin HCl was encapsulated in mucoadhesive microspheres by an ionic gelation method. Polymers with different combinations were tried, and the resulting mucoadhesive COM/Na-Alg microspheres were assessed for particle size (mm) PS/Y1, drug encapsulation efficiency DEE (%)/Y2, and in vitro percentage cumulative drug release R12h/Y3 using Drug Design Expert software version 10. The response surface methodology by a 32-central composite design predicted optimal synthesis parameters for the microspheres to be 295 mg for COM and 219 mg for Na-Alg. An optimized formulation was prepared under these conditions and used to evaluate the micrometric properties, morphology and structural characteristics, swelling behavior, in vitro drug release, and kinetics. Acute toxicity studies were carried out on blank COM/Na-Alg microspheres to deem them safe for in vivo studies. The DEE (%) was calculated to be 85.8 ± 1.67, whereas scanning electron microscopy (SEM) showed a coarse surface with characteristic wrinkles and cracks with an optical microscopic particle size of 0.96 ± 2.45. The ex vivo tests showed great mucoadhesive properties and good swelling behavior with pH-responsive drug release and a significant reduction in in vivo blood glucose levels. The results advocated the use of optimized microspheres to enhance the bioactivity with a possible dose reduction, making it less symptomatic, reducing the expense of the treatment, and subsequently facilitating better patient compliance.
Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration

Ildikó Bácskay,Boglárka Papp,Péter Pártos,István Budai,Ágota Pető,Pálma Fehér,Zoltán Ujhelyi,Dóra Kósa

DOI: https://doi.org/10.3390/pharmaceutics16010046

IF: 6.525

2023-12-29

Pharmaceutics

Abstract:The development of oral insulin drug delivery systems is still an ongoing challenge for pharmaceutical technology researchers, as the formulation process has to overcome a number of obstacles due to the adverse characteristics of peptides. The aim of this study was to formulate different sodium-alginate microparticles as a possible method for oral insulin administration. In our previous studies, the method has been successfully optimized using a small model peptide. The incorporation of insulin into alginate carriers containing nonionic surfactants has not been described yet. In order to enhance the absorption of insulin through biological barriers, Labrasol ALF and Labrafil M 2125 CS were selected as permeation-enhancing excipients. They were applied at a concentration of 0.10% (v/v%), along with various combinations of the two, to increase oral bioavailability. Encapsulation efficiency showed sufficient drug incorporation, as it resulted in over 80% in each composition. In vitro dissolution and enzymatic stability test results proved that, as a pH-responsive polymer, alginate bead swelling and drug release occur at higher pH, thus protecting insulin against the harsh environment of the gastrointestinal tract. The remaining insulin content was 66% due to SIF degradation after 120 min. Permeability experiments revealed the impact of permeation enhancers and natural polymers on drug absorption, as they enhanced drug transport significantly through Caco-2 cells in the case of alginate microparticle formulations, as opposed to the control insulin solution. These results suggest that these formulations are able to improve the oral bioavailability of insulin.

pharmacology & pharmacy
Formulation and Evaluation of Extended Release Oral Suspension of Metformin Hydrochloride

Dipali Patil,Shashikant Barhate,Manoj Bari,Shaikh Samir

DOI: https://doi.org/10.52711/0975-4377.2024.00002

2024-02-22

Research Journal of Pharmaceutical Dosage Forms and Technology

Abstract:The research scheme of formulation and evaluation of extended-release oral suspension of metformin hydrochloride with the objective to develop a stable, redispersible oral liquid suspension based on extended-release pellets to facilitate swallowing in patients with diabetes. Pellets were prepared by using Bed Coating During Sliding method with the Metformin hydrochloride used as antidiabetic drug and various polymers. Extended release was affected by the ethylcellulose coating of drug formulation used as coating agent, MCC, Lactose, PVP K-30 Prepared metformin hydrochloride pellets putted in to prepared sugar free syrup vehicle using polymers like Xanthan Gum as a suspending agent for uniform drug distribution, Sorbitol solution, Aspartame are artificial sweeteners, Sodium Citrate, Potassium sorbate, Methyl paraben. The formulation was optimized based on Design expert software and Central Composite Design was used for study. Drug and polymers were studied for compatibility and interaction study, carried out by FTIR and DSC and found to be compatible to each other. The Redispersibility, Sedimentation volume, Sedimentation rate, Rheological Study, Viscosity, Specific gravity, Particle Size, dissolution study and %Drug content of formulated batches was evaluated. All the results were within the acceptable pharmacopeial limits and were evaluated statistically by using one way ANOVA test for quadratic model. From the result, MET6 batch was observed optimized formulation because up to 8 hrs 85.25% drug was released. kinetic studies of the drug release for optimized formulation follows zero order kinetics.

Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.

Finite-time consensus of heterogeneous multi-agent system with external disturbances

Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet

Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance

FORMULATION DEVELOPMENT AND OPTIMIZATION OF EMPAGLIFLOZIN FILM COATED TABLET USING QUALITY-BY-DESIGN APPROACH

Peristaltic squeezing of sperm bundles at the late stage of spermatogenesis in the silkworm, Bombyx mori

[Arrhythmologic study of 50 patients with arrhythmogenic disease of the right ventricle: prognostic implications].

Design, preparation, and in vitro evaluation of gastroretentive floating matrix tablet of mitiglinide

Development of 3D-Printed, Liquisolid and Directly Compressed Glimepiride Tablets, Loaded with Black Seed Oil Self-Nanoemulsifying Drug Delivery System: In Vitro and In Vivo Characterization

Formulation, Optimization and Evaluation of Solid SMEDDS of Pioglitazone

FORMULATION DEVELOPMENT AND OPTIMISATION OF FAST DISSOLVING BUCCAL FILMS LOADED GLIMEPIRIDE SOLID DISPERSION WITH ENHANCED DISSOLUTION PROFILE USING CENTRAL COMPOSITE DESIGN

Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy

Formulation, design and optimization of antidiabetic drug loaded microspheres

Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats

Preparation and Characterization of Febuxostat Nanosuspension as Fast Dissolving Oral Film

Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine

STATISTICAL DESIGN OF EXPERIMENT-BASED FORMULATION DEVELOPMENT AND OPTIMIZATION OF FLOATING MATRIX TABLET OF ANTI-EMETIC DRUG

Synthesis and characterization of novel xanthan gum-based pH-sensitive hydrogel for metformin hydrochloride release

Formulation, Statistical Optimization, and In Vivo Pharmacodynamics of Cydonia oblonga Mucilage/Alginate Mucoadhesive Microspheres for the Delivery of Metformin HCl

Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration

Formulation and Evaluation of Extended Release Oral Suspension of Metformin Hydrochloride